Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
In addition, many of these patients will have additional risk factors for delayed gastric emptying (for example, diabetes or obesity) which must be taken into consideration
People who remain on GLP-1 therapy for 1224 months (rather than stopping after 6 months) show better long-term weight maintenance because their brains have more time to adapt to lower body weight
Wegovy is specifically approved for weight management in adults with obesity or those who are overweight with weight-related health conditions
This calculator estimates concentration, injection volume (mL), U-100 syringe units, total medication in the vial, estimated doses per vial, and estimated weeks based on the values you enter
They will know or recommend what is best for you
